Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Debt Ratio (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Debt Ratio for 4 consecutive years, with 0.81 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 51.55% to 0.81 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.81 through Dec 2025, up 51.55% year-over-year, with the annual reading at 0.81 for FY2025, 51.55% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.81 at Phathom Pharmaceuticals, down from 0.86 in the prior quarter.
  • The five-year high for Debt Ratio was 0.86 in Q3 2025, with the low at 0.33 in Q4 2023.
  • Average Debt Ratio over 4 years is 0.56, with a median of 0.54 recorded in 2024.
  • The sharpest move saw Debt Ratio tumbled 42.38% in 2023, then soared 89.82% in 2025.
  • Over 4 years, Debt Ratio stood at 0.58 in 2022, then crashed by 42.38% to 0.33 in 2023, then surged by 59.84% to 0.53 in 2024, then surged by 51.55% to 0.81 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.81, 0.86, and 0.82 for Q4 2025, Q3 2025, and Q2 2025 respectively.